低密度脂蛋白密度和动脉样硬化. 解开连接的连接
1Department of Pediatrics, MACC Fund Research Center, Medical College of Wisconsin, Milwaukee 53226.
JAMA
|July 27, 1994
概括
小而密集的低密度脂蛋白 (LDL) 颗粒在冠状动脉疾病中更为普遍. 了解这种与动脉动脉生成的联系是揭示疾病机制的关键.
科学领域:
- 心血管科学 心血管科学
- 脂质代谢 脂质代谢是什么
- 动脉样硬化研究 动脉样硬化研究
背景情况:
- 低密度脂蛋白 (LDL) 是异质的,密度和大小各不相同.
- 小而密集的LDL颗粒越来越被认为对心血管健康具有重要意义.
研究的目的:
- 审查LDL密度与冠状动脉疾病 (CAD) 之间的关联.
- 为了探索脂质过氧化作用和异构体残留假设.
- 检查影响LDL密度的因素.
主要方法:
- 系统的文学搜索英语语言研究和LDL组成和大小的评论.
- 临床研究对LDL密度和CAD的批判性审查.
- 分析LDL密度,其他脂蛋白和影响因素之间的关系.
主要成果:
- 小而密集的LDL颗粒更常见于CAD和相关疾病,如糖尿病和家族结合性高脂血症.
- 密集的LDL与与浮动的LDL相比,与更有异性质的脂质蛋白样本有关.
- 甘油三水平显著影响LDL亚群的形成.
结论:
- 密集的LDL和动脉动脉生成之间的关系为动脉样硬化的基本机制提供了关键的见解.
- 对密集的LDL进行进一步的研究对于理解和潜在治疗心血管疾病至关重要.
相关概念视频
Inflammation
Overview
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease I: Introduction
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...


